Assoc. Prof. İlim Irmak is a dedicated medical professional specializing in respiratory medicine. Appointed Associate Professor in 2021, M.D. Irmak combines academic rigor with clinical practice at Acibadem Health Group since 2024. Their work focuses on improving respiratory care through patient-centered clinical practice and active involvement in research and professional societies. Professional affiliations include membership in the European Respiratory Society, the Respiratory Research Society of Turkey, and the Turkish Thoracic Society, reflecting a strong commitment to advancing respiratory science and collaboration within the medical community.
Education
- 2021 Associate Professor
- 2013 Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital Chest Diseases
- 2008 Istanbul University Cerrahpasa Faculty of Medicine
Experience
- 2024 Acibadem Health Group
- 2019 – 2021 Hacettepe University Faculty of Medicine Department of Chest Diseases / Lecturer
Memberships
- European Respiratory Society
- Respiratory Research Society of Turkey
- Turkish Thoracic Society
Publications
- Patients with cystic fibrosis who could not receive the CFTR modulator treatment: What did they lose in 1 year?.
Pediatric Pulmonology. (SCI-Expanded)-Q2 (2023) Uytun, S., Cinel, G., Eryılmaz Polat, S., Özkan Tabakçı, S., Kiper, N., Yalçın, E., … & Doğru, D - A case-control study of the effects of Aspergillus clinical phenotypes on pulmonary functions in patients with cystic fibrosis
Pediatric Pulmonology. (SCI-Expanded)-Q2 (2023) Nayir Buyuksahin, H., Dogru, D. E. N. I. Z., Emiralioglu, N., Ademhan Tural, D., Ozsezen, B., Sunman, B., Irmak, I.,… & Kiper, N - Bone Mineral Density in Lung Transplant Recipients: Experience of A Referral Lung Transplantation Center
Turkish Journal of Internal Medicine, 5(3), 156-162 82 (2023) GÜNEY, P. A., IRMAK, İ., HALİS, A. N., & SARIBAŞ, E. - Clinical characteristics of patients requiring lung transplantation referral in national cystic fibrosis registry data.
The Turkish journal of pediatrics, 65(2), 257-268. (SCI-Expanded)-Q4 (2023) Onay, Z. R., Eyübo?lu, T. Ş., Aslan, A. T., Gürsoy, T. R., Yalçın, E., Kiper, N., … & Do?ru, D. - Post discharge mortality in the first wave of COVID? 19 in Turkey
Asian Pacific Journal of Tropical Medicine, 15(11), 479-484. (SCI-Expanded)-Q2 (2022) Fakili, F., Cetinkaya, P. D., Baydar, O., Baris, S. A., Kokturk, N., Kul, S., … & Bayram, H. - The association of antiviral drugs with COVID-19 morbidity: The retrospective analysis of a nationwide COVID-19 cohort.
Frontiers in medicine, 2587. (SCI-Expanded)-Q2 (2022) Babayigit, C., Kokturk, N., Kul, S., Cetinkaya, P. D., Atis Nayci, S., Argun Baris, S., Irmak, I. … & Bayram, H. - ssociation Between Known Close Contact History and Severity of COVID-19 Pneumonia: A Preliminary Evidence Supporting Importance of Filiation
Turkish Thoracic Journal, 23(3), 196-202. (2022) Irmak, I., Inam, M. G., Tekin, F., & Damadoglu, E. - The success of the Cystic Fibrosis Registry of Turkey for improvement of patient care.
Pediatric pulmonology, 57(5), 1245-1252. (SCI-Expanded)-Q2 Asfuroglu, P., Sismanlar Eyuboglu, T., Aslan, A. T., Gursoy, T. R., Emiralioglu, N., Yalcin, E.,I.Irmak … & Dogru, D. - Neutrophil-to-lymphocyte Ratio as a Predictor of Prognosis in Patients with Small Cell Lung Cancer: A Retrospective Study
Southern Clinics of Istanbul Eurasia, 32(3). (2021) Guney, P. A., Irmak, I., Kasapoglu, U. S., & Arinc, S. - Cuban Blue Scorpion Venom and Lung Carcinoma: Is it Always True What Does Not Kill Me Makes Me Stronger?.
Turk Thorac Journal/ Turk Thorac J 2021; 22(3): 265-266 (2021) Damadoglu, E., Irmak, I., & Kalyoncu, A. F.
